분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2017-09-20 00:22:08 , Hit : 580
 Alcoholism Gene Therapy Shows Promise


GEN News Highlights
More »
September 19, 2017


http://www.genengnews.com/gen-news-highlights/alcoholism-gene-therapy-shows-promise/81254942?utm_medium=newsletter&utm_source=GEN+Daily+News+Highlights&utm_content=02&utm_campaign=GEN+Daily+News+Highlights_20170919

Scientists' development could feasibly help to treat alcoholism by causing unpleasant physical side effects in individuals who imbibe. [kazan.vperemen.com/ Wilimedia]

Scientists in North and South America have developed a form of gene therapy that could feasibly help to treat alcoholism by causing unpleasant physical side effects in individuals who imbibe. The approach harnesses a short hairpin RNA (shRNA), which is delivered to liver cells using an adeno-associated viral (AAV) vector to prevent expression of a liver enzyme that is involved in metabolizing ethanol into acetate.

The researchers, headed by Anamaria C. Sanchez, Ph.D.,  from the University of Chile in Santiago, and R. Jude Samulski, Ph.D., from the University of North Carolina, Chapel Hill, conclude that their in vitro studies “suggest that gene therapy could be a useful tool for the treatment of alcoholism.” They report on their research in Human Gene Therapy, in a paper entitled, “AAV Gene Therapy for Alcoholism: Inhibition of Mitochondrial Aldehyde Dehydrogenase Enzyme Expression in Hepatoma Cells.”

Alcohol is the most commonly used addictive substance globally and causes some 3.3 million deaths every year, which approximates to 5.9% of all deaths, Prof. Sanchez and colleagues write. In the U.S., excessive alcohol consumption in 2010 was estimated to have cost the nation $250 billion, primarily due to loss in productivity, healthcare, and societal ills. There are currently three approved medications in the U.S. for treating alcohol dependence—disulfiram, naltrexone, and acamprosate. However, as Dr. Sanchez et al. point out, none is widely prescribed because they have limited efficacy, cause side effects, and patient compliance is poor.

Ethanol is metabolized in the liver in two stages: first the oxidation of ethanol to form acetaldehyde. This reaction is catalyzed by the cytosolic enzyme alcohol dehydrogenase (ADH). The acetaldehyde is then converted to acetate by a mitochondrial isoform of the enzyme aldehyde dehydrogenase, ALDH2.

About half of the Asian population has one copy of the normal ALDH2 gene and one mutant copy of the gene that encodes an inactive enzyme. These heterozygous individuals have a reduced capacity to metabolize acetaldehyde, so when they drink alcohol, the acetaldehyde accumulates in the blood and causes physical effects such as facial flushing, dizziness, hypotension, and palpitations. This is enough to prompt people to reduce their alcohol consumption and effectively prevent alcoholism.

ALDH2 is a recognized target for treating alcohol dependency. Dr. Sanchez and colleagues have now developed an shRNA that is designed to silence the expression of ALDH2 and can be delivered to cells using a self-complementary AAV2 (scAAV2) vector. They tested the shRNA in both a specially developed ALDH2-expressing human liver cell line, HEK-293/ALDH2, and to HepG2 liver cancer cells. The results showed that the vector-delivered shRNA significantly reduced ALDH2 transcript and protein levels. “In both cell lines, ALDH2 RNA levels were reduced by 90% and protein expression was inhibited by 90% and 52%, respectively, 5 days post infection,” they stated. In addition, transduced cells exposed to ethanol accumulated up to 50% higher levels of acetaldehyde than cells that weren’t treated using the shRNA.

The researchers constructed and tested five different shRNA sequences, and they chose one for use with the scAAV plasmid. They suggest that using more than one sequence could have potentially greater effects. “Further experiments could use a combination of these shRNA sequences in the search for an additive effect to knock down ALDH2 expression,” they conclude.

Commenting on the study, Human Gene Therapy editor-in-chief, Terence R. Flotte, M.D., said that substance abuse, including alcohol abuse, and associated suicide, are responsible for “an alarming increase in mortality among middle-aged Americans.” Prof. Flotte is the Celia and Isaac Haidak Professor of Medical Education and dean, provost, and executive deputy chancellor at the University of Massachusetts Medical School (Worcester, MA). “What has not often been recognized is that genetic factors account for over 79% of the risk of alcoholism, based on twin studies,” he added. “These investigators have targeted one of the best established contributors and demonstrated strong proof-of-concept data with a rAAV vector-mediated shRNA approach. This bodes well for future development of this therapy.”

Human Gene Therapy, published by Mary Ann Liebert, Inc., is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies.The above article was first published in the September 2017 issue of Human Gene Therapy with the title “AAV Gene Therapy for Alcoholism: Inhibition of Mitochondrial Aldehyde Dehydrogenase Enzyme Expression in Hepatoma Cells”. The views expressed here are those of the authors and are not necessarily those of Human Gene Therapy, Mary Ann Liebert, Inc., publishers, or their affiliates. No endorsement of any entity or technology is implied.







1207   CRISPR Used in Human Embryos to Probe Gene Function  이성욱 2017/09/22 580
  Alcoholism Gene Therapy Shows Promise  이성욱 2017/09/20 580
1205   DNA Construction  이성욱 2017/09/15 656
1204   Cargo-Sorting DNA Robots  이성욱 2017/09/15 1137
1203   From Startups to Moguls] CRISPR 유전자가위 없이 편집한다? Homology Medicines  이성욱 2017/09/11 603
1202   Outsourcing Gene Editing to the Public-Online Game Challenges Players to Design CRISPR On/Off Switch  이성욱 2017/09/05 719
1201   Scientists Doubt Results of CRISPR’d Embryos  이성욱 2017/09/02 536
1200   Scientists Look to Epigenetics to Thwart Viruses  이성욱 2017/09/02 706
1199   First CAR T-Cell Therapy Approved in U.S.  이성욱 2017/09/01 688
1198   UPDATED: FDA ushers in a new era in cancer treatment with ‘historic’ CAR-T approval for Novartis  이성욱 2017/08/31 693
1197   “유전자 치료 법률 금지 한국 유일” vs “생명체 설계도 바꾸는 건 문제”  이성욱 2017/08/28 722
1196   Cancer Onset May Be Caused by Immune System Fighting Viruses  이성욱 2017/08/25 715
1195   유전자 가위로 바이러스 제거한 '청정 돼지' 나왔다  이성욱 2017/08/24 759
1194   CRISPR Corrects RNA-based Disease Defects  이성욱 2017/08/14 731
1193   Uncovering Functions of Circular RNAs  이성욱 2017/08/14 717
1192   First In Vivo Function Found for Animal Circular RNA  이성욱 2017/08/14 751
1191   Gene Study Based on RNA Interference May Lead to New Liver Cancer Therapies  이성욱 2017/08/14 808
1190   Resistance to HIV Engineered Via CRISPR  이성욱 2017/08/07 711
1189   [바이오토픽] 드디어 올 것이 왔다: CRISPR, 생존가능 인간배아의 질병초래 유전자 교정 성공  이성욱 2017/08/03 728
1188   Engineered Human Liver Tissue Grows in Mice  이성욱 2017/07/25 777

[1][2][3] 4 [5][6][7][8][9][10]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN